Head-to-head · WeighScore
Auren Rx vs Ivim Health
The verdict
Auren Rx takes it — 72.9/100 to 59.6/100.
Auren Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Auren Rx charges the same $149 for semaglutide and tirzepatide, which removes the usual reason to start on the weaker molecule.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Auren Rx | Ivim Health |
|---|---|---|
| WeighScore | 72.9/100 | 59.6/100 |
| Grade | C | C |
| Site position | #83 | #385 |
| Semaglutide | $149/mo (auto-refill; a single month with no commitment is $179) | $149/mo (starting dose, medication and program fee, compounded) |
| Tirzepatide | $149/mo (auto-refill; a single month with no commitment is $179) | $224/mo (starting dose, medication and program fee, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #83 · C
Strengths
- Semaglutide and tirzepatide cost the same, so the choice of molecule is clinical rather than budgetary
- A microdose lane is priced separately at $129 on auto-refill rather than folded into the standard figure
- Names its dispensing pharmacy, VialsRX, with a street address and a phone number in Houston, Texas
- Names a prescribing physician and practice, and publishes support hours of Monday to Friday, 9 AM to 6 PM Eastern
Where it loses points
- The $149 figure requires enrolling in auto-refill; a single month with no commitment is $179
- Two different medical groups are named for the same service — Wasef Health, PC on the contact page and FAQ, Beluga Health, P.A. in the telehealth consent
- Product pages advertise a free online visit while the Terms make the initial online visit and any laboratory testing the patient's responsibility
- The FAQ says all 50 states, the Terms say service is available only in certain states, and no list is published
- No compounding class is stated for VialsRX, so whether it operates under 503A or 503B is unknown
- NAD+ is priced at two different figures on the same site, which is not reassuring about the GLP-1 numbers
Site position #385 · C
Strengths
- Both molecules are priced on one page, each quoted as medication and program charge included rather than as a bare drug price
- A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
- The first month of the membership is free
Where it loses points
- A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
- The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
- Both figures are 'starting at' rates, so the cost of a titrated dose is not published
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.